Watanabe Todd, See Remarks, sold Arcutis Biotherapeutics, Inc. ($ARQT) shares on the open market 18 times in the past year, totaling $5.7 million. The most recent sale was on March 2, 2026. These transactions rank 1,753rd among 11,678 insiders in our database, below the average of $8.6 million per seller across 6.37 trades. No open market purchases occurred.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | A | Stock Option (right to buy) | 266000 | $0.00 | 266,000.0000 | 132,885,000 | 9999.99% | 0.20% |
| Feb. 27, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | A | Common Stock | 102000 | $0.00 | 1,056,440.0000 | 132,885,000 | 10.69% | 0.08% |
| March 2, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | S | Common Stock | 36281 | $25.16 | 1,020,159.0000 | 132,885,000 | 3.43% | 0.03% |
| March 2, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | S | Common Stock | 1068 | $25.91 | 1,019,091.0000 | 132,885,000 | 0.10% | 0.00% |
| Feb. 2, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | S | Common Stock | 19833 | $25.50 | 954,440.0000 | 132,885,000 | 2.04% | 0.01% |
| Nov. 24, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | S | Common Stock | 48945 | $30.36 | 973,671.0000 | 132,885,000 | 4.79% | 0.04% |
| Nov. 21, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | S | Common Stock | 1055 | $30.00 | 1,026,972.0000 | 132,885,000 | 0.10% | 0.00% |
| Nov. 3, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | S | Common Stock | 69 | $25.40 | 1,028,027.0000 | 132,885,000 | 0.01% | 0.00% |
| Nov. 3, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | S | Common Stock | 11478 | $24.71 | 1,028,096.0000 | 132,885,000 | 1.10% | 0.01% |
| Oct. 28, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | S | Common Stock | 40000 | $25.03 | 1,039,574.0000 | 132,885,000 | 3.71% | 0.03% |
| Oct. 2, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | S | Common Stock | 20739 | $20.04 | 1,079,574.0000 | 132,885,000 | 1.88% | 0.02% |
| Oct. 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | S | Common Stock | 9261 | $20.02 | 1,100,313.0000 | 132,885,000 | 0.83% | 0.01% |
| Oct. 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | S | Common Stock | 15000 | $18.91 | 1,109,574.0000 | 132,885,000 | 1.33% | 0.01% |
| Sept. 9, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | S | Common Stock | 504 | $17.52 | 1,124,574.0000 | 120,957,633 | 0.04% | 0.00% |
| Sept. 8, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | S | Common Stock | 9625 | $17.54 | 1,125,078.0000 | 120,957,633 | 0.85% | 0.01% |
| Aug. 4, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd | See Remarks | S | Common Stock | 11547 | $14.33 | 1,134,703.0000 | 120,957,633 | 1.01% | 0.01% |
| June 10, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | G | Common Stock | 997 | $0.00 | 1,120,840.0000 | 120,957,633 | 0.09% | 0.00% |
| June 10, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | G | Common Stock | 997 | $0.00 | 1,120,840.0000 | 120,957,633 | 0.09% | 0.00% |
| June 10, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | G | Common Stock | 997 | $0.00 | 1,120,840.0000 | 120,957,633 | 0.09% | 0.00% |
| June 10, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | G | Common Stock | 997 | $0.00 | 1,121,837.0000 | 120,957,633 | 0.09% | 0.00% |
| May 2, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | S | Common Stock | 11448 | $15.19 | 1,144,935.0000 | 120,957,633 | 0.99% | 0.01% |
| March 25, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | S | Common Stock | 2171 | $17.56 | 1,156,383.0000 | 120,957,633 | 0.19% | 0.00% |
| March 24, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | S | Common Stock | 1500 | $17.52 | 1,158,554.0000 | 120,957,633 | 0.13% | 0.00% |
| March 17, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | S | Common Stock | 1200 | $17.61 | 1,160,054.0000 | 120,957,633 | 0.10% | 0.00% |
| Feb. 28, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | A | Stock Option (right to buy) | 396000 | $0.00 | 396,000.0000 | 120,957,633 | 9999.99% | 0.33% |
| Feb. 28, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | A | Common Stock | 151000 | $0.00 | 1,186,269.0000 | 120,957,633 | 14.59% | 0.12% |
| March 3, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | S | Common Stock | 20880 | $13.03 | 1,165,389.0000 | 120,957,633 | 1.76% | 0.02% |
| March 4, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | S | Common Stock | 4135 | $13.28 | 1,161,254.0000 | 120,957,633 | 0.35% | 0.00% |
| Feb. 3, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | S | Common Stock | 19301 | $12.70 | 1,035,269.0000 | 120,957,633 | 1.83% | 0.02% |
| Dec. 20, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | S | Common Stock | 15000 | $15.17 | 1,054,570.0000 | 124,302,317 | 1.40% | 0.01% |
| Nov. 30, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | P | Common Stock | 2038 | $7.11 | 1,069,570.0000 | 124,302,317 | 0.19% | 0.00% |
| May 31, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | P | Common Stock | 4000 | $1.69 | 1,067,532.0000 | 69,305,487 | 0.38% | 0.01% |
| Nov. 4, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | S | Common Stock | 13871 | $8.68 | 1,063,532.0000 | 124,302,317 | 1.29% | 0.01% |
| Aug. 2, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | S | Common Stock | 14487 | $9.02 | 1,077,403.0000 | 69,305,487 | 1.33% | 0.02% |
| May 2, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | S | Common Stock | 13783 | $8.74 | 1,091,890.0000 | 69,305,487 | 1.25% | 0.02% |
| March 4, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | S | Common Stock | 14903 | $11.12 | 1,105,673.0000 | 69,305,487 | 1.33% | 0.02% |
| Feb. 28, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | S | Common Stock | 2465 | $10.60 | 1,120,576.0000 | 69,305,487 | 0.22% | 0.00% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | A | Common Stock | 21666 | $0.00 | 879,825.0000 | 69,305,487 | 2.52% | 0.03% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | A | Common Stock | 94050 | $0.00 | 1,006,941.0000 | 69,305,487 | 10.30% | 0.14% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | A | Common Stock | 33066 | $0.00 | 912,891.0000 | 69,305,487 | 3.76% | 0.05% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | D | Stock Option (right to buy) | 232200 | $0.00 | 0.0000 | 69,305,487 | 100.00% | 0.34% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | D | Stock Option (right to buy) | 188100 | $0.00 | 0.0000 | 69,305,487 | 100.00% | 0.27% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | D | Stock Option (right to buy) | 99200 | $0.00 | 0.0000 | 69,305,487 | 100.00% | 0.14% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | D | Stock Option (right to buy) | 65000 | $0.00 | 0.0000 | 69,305,487 | 100.00% | 0.09% |
| Feb. 13, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | A | Common Stock | 116100 | $0.00 | 1,123,041.0000 | 69,305,487 | 11.53% | 0.17% |
| Jan. 12, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | A | Common Stock | 125000 | $0.00 | 627,019.0000 | 69,305,487 | 24.90% | 0.18% |
| Jan. 12, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Watanabe Todd Franklin | See Remarks | A | Stock Option (right to buy) | 410000 | $0.00 | 410,000.0000 | 69,305,487 | 9999.99% | 0.59% |